October 28 (SeeNews) - The District Court in Ljubljana has lifted an earlier ban that prohibited Slovenian drug maker Krka from manufacturing and selling the antipsychotic drug Zolrix or other products containing olanzapine as active pharmaceutical ingredient in Slovenia, Krka said on Tuesday.